William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- STEM-Talk: Dom D’Agostino discusses advances in ketogenic metabolic therapies and hyperbaric oxygen therapies
- IHMC’s new humanoid Alex aces its first off-site, off-tether demonstration
- A Letter From Our CEO
- IHMC project helps pioneer new tools for warfighters
- STEM-Talk: Doug Cooke talks about strengths and flaws of NASA’s Artemis mission
- IHMC hosts national workshop on collaborative autonomy
- Community turnout lifts IHMC clinical trial to a great start
- Two IHMC researchers named to top posts in worldwide organizations
- Public learns about robots, drones, virtual reality, Healthspan advances and more at open house